Isoliquiritigenin

CAS No. 961-29-5

Isoliquiritigenin( GU 17 | ILQ | ISL )

Catalog No. M16863 CAS No. 961-29-5

Isoliquiritigenin, an anti-tumor flavonoid from the root of Glycyrrhiza glabra, inhibits aldose reductase with an IC50 of 320 nM.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 29 In Stock
10MG 37 In Stock
25MG 49 In Stock
50MG 69 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Isoliquiritigenin
  • Note
    Research use only, not for human use.
  • Brief Description
    Isoliquiritigenin, an anti-tumor flavonoid from the root of Glycyrrhiza glabra, inhibits aldose reductase with an IC50 of 320 nM.
  • Description
    Isoliquiritigenin, an anti-tumor flavonoid from the root of Glycyrrhiza glabra, inhibits aldose reductase with an IC50 of 320 nM.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    GU 17 | ILQ | ISL
  • Pathway
    Endocrinology/Hormones
  • Target
    Reductase
  • Recptor
    Aldose reductase
  • Research Area
    Other Indications
  • Indication
    ——

Chemical Information

  • CAS Number
    961-29-5
  • Formula Weight
    256.25
  • Molecular Formula
    C15H12O4
  • Purity
    >98% (HPLC)
  • Solubility
    Ethanol: 51 mg/mL (199.02 mM); DMSO: 51 mg/mL (199.02 mM)
  • SMILES
    O=C(C1=CC=C(O)C=C1O)/C=C/C2=CC=C(O)C=C2
  • Chemical Name
    (E)-1-(2,4-dihydroxyphenyl)-3-(4-hydroxyphenyl)prop-2-en-1-one

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Aida K, et al. Planta Med, 1990, 56(3), 254-258.
molnova catalog
related products
  • Lidorestat

    Lidorestat (IDD-676) is an aldose reductase inhibitor (IC50: 5 nM) with effective, selective and oral activity. Lidorestat improves nerve conduction and reduces the formation of cataracts.

  • BYAKANGELICIN(b)

    BYAKANGELICINa main furanocoumarin constituent isolated and characterized as an aldose reductase inhibitorand is effective for the treatment of sugar cataracts and diabetic neuropathy and hence might be useful as a lead compound for the development of new type drugs for clinical use.

  • Ganoderic acid C2

    Ganoderic acid C2 has anti-inflammatory,and anti-tumor-promoting activities. Ganoderic acid C2 can inhibit histamine release, it also has inhibitory effects on the induction of Epstein-Barr Virus early antigen.